- 暂无数据
简体中文
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, Yawei Group signed a complete set of sheet metal laser processing equipment with Hubei Zhonggang Metal Xianning Second Production Base, adding bricks and tiles to the takeoff of Zhonggang Metal Business. After full production, the annual production of various aluminum metal plates will exceed 6 million square meters, and Zhonggang Metal will usher in another leap forward development!Zhon...
Recently, Qing Guangyan, a researcher team from the Research Group on Bioseparation and Interface Molecular Mechanism (1824 Group) of Biotechnology Research Department of Dalian Institute of Chemical Physics, Chinese Academy of Sciences, designed and prepared a highly solid cellulose photonic hydrogel with reconfigurability and mechanical discoloration. This preparation method opens up a new way t...
TDK Corporation (TSE: 6762) announced the introduction of the new NTCWS series of NTC thermistors with gold wire bonding. These bonding NTC thermistors can be installed in packages via gold wire bonding to enable high precision temperature detection of laser diodes (LD) for optical communication. The series will begin mass production in September 2023.The use of LD devices in optical communication...
Los Alamos National Laboratory (LANL) has developed a method for a quantum light emitter that stacks two different atomically thin materials together to achieve a light source that produces a stream of circularly polarized single photons. These light sources can in turn be used for a variety of quantum information and communication applications.According to Los Alamos researcher Han Htoon, the wor...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...